In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and Terranova Medica, LLC. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Partners designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Partners designates this continuing education activity for 1.0 contact hours (0.10 CEUs) of the Accreditation Council for Pharmacy Education. 

Universal Activity Number - JA4008073-9999-25-238-H01-P

Type of Activity: Application

The maximum number of hours awarded for this Continuing Nursing Education is 1 contact hour. 

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.

Faculty Disclosures

Luis Ostrosky-Zeichner, MD, FACP, FIDSA, FSHEA, FECMM, CMQ
CONSULTANT, ADVISOR, OR SPEAKER: Scynexis, Melinta, GSK, Pulmocide, F2G, Basilea, Viracor Eurofins, Gilead

Angel Desai, MD, MPH
NOTHING TO DISCLOSE

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive CE credit, learners must follow these steps during the period from September 16, 2025 through September 15, 2026:
If you wish to receive acknowledgment for completing this activity, please follow the steps below:

1. Review the objectives and disclosures
2. Study the educational content
3. Successfully complete activity quiz(zes)
4. Complete the activity evaluation

You must receive a test score of at least 75% and respond to all evaluation questions to receive a certificate.

For Pharmacists: Upon successfully completing the post-assessment, your credit will be submitted to CPE Monitor.  Please check your NABP account within thirty (30) days to make sure the credit has posted.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.